drugset / Trial / NCT05437471
Effects of Co-treatment on Endometrial abv3-integrin Expressions in Women With Recurrent Implantation Failure
RandomizedParallel-groupOpen-labelSupportive care
Summary
To compare the abv3-integrin expression in endometrium tissue among RIF women between the GnRH analogue with Aromatase Inhibitor (Group A) , GnRH analogue with progesterone (Group B) and GnRH analogue alone as control group (Group C)
Timeline
- Start
- 2020-01-01
- Primary completion
- 2021-12-30
- Completion
- 2022-05-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dydrogesterone | Other / unclassified | 10 mg | — |
| Comparator | Letrozole | Other / unclassified | 10 mg | — |
| Comparator | Leuprolide | Other / unclassified | 11.25 mg | — |